产品名称 | Palmitoylethanolamide |
产品货号 | Axon 1211 CAS [544-31-0] MF C18H37NO2MW 299.49 Purity: 98% Soluble in Ethanol Description A putative endocannabinoid; selective GPR55 agonist References Certificates Categories Extra info V di Marzo et al. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem. J. 2001, 358, 249-255. S Conti et al. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br. J. Pharmacol. 2002, 135, 181-187. Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation GPR55 A15 Endocannabinoid; GPR55 agonist Chemical name Hexadecanoic acid (2-hydroxy-ethyl)-amide Parent CAS No. [544-31-0] Order Size Unit Price Stock 20 mg €75.00 In Stock |
产品价格 | 现货询价,电话:010-67529703 |
产品规格 | |
产品品牌 | axonmedchem |
产品概述 | |
产品详情 |
PalmitoylethanolamideAxon 1211 CAS [544-31-0] MF C18H37NO2
Description
A putative endocannabinoid; selective GPR55 agonist
Endocannabinoid; GPR55 agonist
Chemical nameHexadecanoic acid (2-hydroxy-ethyl)-amide Parent CAS No.[544-31-0] |
产品资料 |